Statin treatment for individuals with Framingham risk under 20 percent has until now been less clear-cut." These data also support the current position taken by the American Heart Association and the U.S. Centers for Disease Control that hsCRP testing is best used in people with intermediate ...
Table 3. Adjusted Odds Ratios (95% Confidence Interval) for Elevated and Clinically Raised Serum C-Reactive Protein (CRP) Concentrations in 3303 Young (Aged 17-39 Years), Nonsmoking, Non–Estrogen-Using Men and Women Without Inflammatory Disease, Cardiovascular Disease, or Diabetes Mellitus*...
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observat... Postmenopausal hormone replacement therapy (HRT) has been shown to elevate C-reactive protein (CRP) levels. Several inflammatory biomarkers, ...
The aim of this study is to investigate the viability of performing initial artificial joint replacement surgery in patients presenting with unexplained elevations in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels. Methods A cohort of 22 patients, comprising 11 cases each fo...
All major cardiovas- cular risk factors, including elevated hsCRP, were over- represented in the myocardial infarction group. The analysis of incident heart failure was restricted to those that developed heart failure unrelated to a myocardial infarction (n = 189), while those that developed ...
Menopause and the risk of coronary heart disease in women. More recently identified risk factors in women include high sensitivity C-reactive protein (hsCRP), homocysteine, and lipoprotein (a). Appropriate management... GA Colditz,WC Willett,MJ Stampfer,... - 《New England Journal of Medicine...
Using 1999 to 2004 NHANES data, we categorized men age ≥50 years and women age ≥60 years by fasting LDL-C and hsCRP levels, excluding individuals with prevalent coronary heart disease, coronary heart disease equivalent (including diabetes), and other JUPITER exclusions. A total of 3.9 ...
Hg), diabetes mellitus (fasting blood glucose >100 mg/dL), smoking status, statin treatment, and a medical history of chronic obstructive pulmonary disease, cancer, chronic renal disease, coronary artery disease (CAD), peripheral arterial disease, cerebrovascular disease, and chronic heart failure. ...
Venous thromboembolism (VTE) is a common, multi-causal disease with potentially serious short- and long-term complications. In clinical practice, there is a need for improved plasma biomarker-based tools for VTE diagnosis and risk prediction. Here we show, using proteomics profiling to screen plasm...
China is a significant contributor to the burden of cardia-cerebrovascular diseases (CVD), with approximately 330 million individuals currently affected by CVD, including around 13 million stroke cases and 11.39 million cases of coronary heart disease [1]. The country is facing the dual challenges ...